Navigation Links
NABP Commends Google's VIPPS-Accreditation Requirement for Internet Pharmacy Advertisers

MOUNT PROSPECT, Ill., Feb. 11 /PRNewswire-USNewswire/ -- Rogue Internet drug outlets will soon find it more difficult to advertise to unsuspecting consumers, thanks to Google's decision to require VIPPS® (Verified Internet Pharmacy Practice Sites(CM)) accreditation. The National Association of Boards of Pharmacy® (NABP®) commends Google for the new restrictions the company has placed on Web sites selling prescription drugs that are seeking to advertise in the United States through Google AdWords.

"For too long, rogue Web sites posing as legitimate pharmacies have continued, unabated, to peddle substandard, tainted, and counterfeit drugs to unwitting patients," says NABP President Gary A. Schnabel, RN, RPh. "Google's policy change is a major step toward ridding the Internet of these operations, and we applaud Google's commitment to patient safety."

On February 9, 2010, Google announced in its Inside AdWords blog that the company will accept ads only from Internet pharmacies in the US that are accredited through the VIPPS program, and from Internet pharmacies in Canada that are accredited by the Canadian International Pharmacy Association. The revised policy allows Internet pharmacies to target ads only to patients in the country in which the pharmacies are accredited.

The AdWords blog indicates that, once the policy change goes into effect later in February 2010, ads for Internet drug outlets that are not accredited by VIPPS or CIPA will no longer appear in Google's sponsored search results.

Since the advent of its VIPPS program more than a decade ago, NABP has been working to protect patients from rogue Internet drug outlets that circumvent pharmacy laws and practice standards established to protect patient health. In February 2008, NABP began an intensive study of Web sites selling prescription drugs and has found that, of the more than 5,000 Internet drug outlets NABP has reviewed, 96% appear to be out of compliance with pharmacy laws and practice standards. These sites dispense dangerous prescription drugs to patients without a valid prescription or medical oversight. The drugs are often unapproved for sale in the US – or any other developed country – and are often substandard, contaminated, or counterfeit.

By contrast, VIPPS-accredited pharmacies have undergone and successfully completed the thorough NABP accreditation process, which includes a thorough review of all policies and procedures regarding the practice of pharmacy and dispensing of medicine over the Internet, as well as an on-site inspection of all facilities used by the site to receive, review, and dispense medicine. For this reason, NABP recommends that patients use VIPPS-accredited Internet pharmacies when buying medicine online.

"Google's policy revision sets an important precedent in the international push to curb the proliferation of rogue Internet drug outlets," NABP President Schnabel notes. "We encourage other search engines to follow Google's lead and take a stand for patient safety."

More information on the VIPPS program, along with a list of VIPPS-accredited pharmacies, is available under Accreditation Programs on the NABP Web site,

NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.

SOURCE National Association of Boards of Pharmacy



SOURCE National Association of Boards of Pharmacy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. IVAC Executive Director Dr. Orin Levine commends Gates Foundation announcement
2. PATH commends the Gates Foundation for their new commitment to fund vaccine innovation and delivery
3. IOM report recommends steps to tackle hepatitis B and C
4. Institute of Medicine recommends stricter resident duty hour regulations to prevent medical errors
5. AARP Commends Idaho for Tackling Wrongfully Denied Health Claims
6. CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital
7. Sleep Specialist Dr. Rafael Pelayo Recommends ASTIs Ecotones Duet Sleep Sound Machine
8. Red Reflex Vision Exam Should Be Given to All Newborns, Report Recommends
9. AARP Commends Legislature For Saving Critical Health Care Program
10. CDA Recommends Halloween Tips for Good Oral Health
11. Stanford study recommends change in treating pulmonary embolisms
Post Your Comments:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... are national leaders when it comes to several aspects of orthopedic care. They ... joint replacements, orthopedic surgeries and general orthopedic care. , Becker's Hospital Review ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Serenity Point Rehabilitation, ... series of recent video interviews with some of the staff members at their recovery ... residential treatment facility, as well as some of the things that make their recovery ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic ... University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester student in ... Carl S. Cleveland III on October 16. , “Katie is very excited and ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... CHICAGO , November 24, 2015 st ... North America (RSNA) taking place in ... in Booth 1122, Hall A. --> st  Scientific Assembly ... America (RSNA) taking place in Chicago ... 1122, Hall A. --> Molecular Dynamics will present its ...
(Date:11/24/2015)... The uptake of recently approved and pipeline premium products for Type ... to 2021, says GBI Research . --> ... 1 Diabetes Mellitus (T1DM), will be a key driver of market growth ... The uptake of recently approved and pipeline premium products for ... growth to 2021, says GBI Research . ...
(Date:11/24/2015)... (NASDAQ: IMMY ) is a national leader ... compounded pharmaceuticals.  The company,s business primarily consists of ... integrative medicine.  Imprimis dispenses compounded pharmaceuticals in all ... California , Texas ... Pennsylvania.  For more information about Imprimis, please visit ...
Breaking Medicine Technology: